Max Robotics — Global Service Robot Directory + US Certification

About

Mikio Ogita is a leading radiation oncologist whose research focuses on reirradiation strategies for recurrent head and neck cancers, with a particular emphasis on advanced stereotactic techniques. His major contributions center on evaluating the efficacy and toxicity of robotic image-guided stereotactic body radiotherapy (SBRT) using CyberKnife, as well as comparing these outcomes with charged particle radiotherapy. In a pivotal 2016 multi-institutional study (47 citations), Ogita examined prognostic factors—especially mucosal ulceration—in 107 patients undergoing CyberKnife reirradiation, providing critical safety and efficacy data. He further advanced the field through a matched-cohort analysis (11 citations) comparing survival outcomes between CyberKnife and charged particle therapy, offering nuanced guidance for treatment selection in this challenging patient population. Ogita’s work has helped define modern reirradiation protocols, balancing tumor control with the risk of severe toxicity. His research is instrumental for clinicians and researchers seeking evidence-based approaches to managing recurrent head and neck malignancies, and his multi-institutional collaborative studies underscore his commitment to improving outcomes through rigorous comparative effectiveness research.